✦ LIBER ✦

Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists

✍ Scribed by Antonio Fernández-Nebro; Eva Tomero; Vera Ortiz-Santamaría; María Carmen Castro; Alejandro Olivé; Manuel de Haro; Rosa García-Vicuña; María Victoria González-Mari; Armando Laffón; Rosario García-Vicuña

Book ID: 116210515
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 93 KB
Volume: 118
Category: Article
ISSN: 1555-7162
DOI: 10.1016/j.amjmed.2005.01.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Priming of NADPH oxidase by tumor necros

Priming of NADPH oxidase by tumor necrosis factor alpha in patients with inflammatory and autoimmune rheumatic diseases

✍ Ralf Miesel; Robert Hartung; Hans Kroeger 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 602 KB

Anti–tumor necrosis factor α therapy in

Anti–tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: A followup report of tolerability and efficacy

✍ Jacques-Eric Gottenberg; Florence Merle-Vincent; Fabrice Bentaberry; Yannick All 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Haplotype restricted differences in in v

Haplotype restricted differences in in vitro production of tumor necrosis factor alpha and lymphotoxin alpha in patients with inflammatory bowel disease and healthy controls

✍ Bouma, G.; Crusius, JBA; Pool, M Oudkerk; Kolkman, JJ; von Blomberg, BME; Meuwis 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Risk of Myeloid Neoplasms in Inflammator

Risk of Myeloid Neoplasms in Inflammatory Bowel Disease Patients Is Linked to Exposure to Thiopurines and Not With Tumor Necrosis Factor-alpha Inhibitors

✍ Deepak, Parakkal; Stobaugh, Derrick J. 📂 Article 📅 2015 🏛 Elsevier Science 🌐 English ⚖ 95 KB

P.1.173: FORMATION OF NON-ORGAN SPECIFIC

P.1.173: FORMATION OF NON-ORGAN SPECIFIC AUTOANTIBODIES (NOSA) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) TREATED WITH ANTI-TUMOR NECROSIS FACTOR-ALPHA AGENTS

✍ I. Bravatà; M. Cappello; C. Randazzo; A. Licata; F. Barbaria; P.L. Almasio; A. C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 84 KB

The Italian Society of Gastroenterology

The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease

✍ Ambrogio Orlando; Alessandro Armuzzi; Claudio Papi; Vito Annese; Sandro Ardizzon 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 344 KB